Ketorolac is a Non-steroidal anti-inflammatory drug (NSAID) and is commercially available as an oral tablet, injectable, nasal spray and as an ophthalmic solution.
It's analgesic properties make it a useful pain management tool across many settings including postoperative pain, rheumatoid arthritis, osteoarthritis, menstrual disorders, headaches, spinal and soft tissue pain, and ankylosing spondylitis. Impressively, ketorolac has a similar efficacy to standard doses of morphine and meperidine making it a useful opioid sparing agent.
Ketorolac is a Non-steroidal anti-inflammatory drug (NSAID) and has antipyretic, analgesic and anti-inflammatory properties. It is indicated for short term management of acute pain that requires the calibre of pain management offered by opioids. Clinicians may choose to initiate ketorolac to manage post-operative pain, spinal and soft tissue pain, rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, menstrual disorders and headaches among other ailments. Regardless of the etiology of pain, patients should use the lowest possible dose, and avoid using ketorolac for an extended period of time (ideally ≤ 5 days). A benefit of choosing ketorolac over other analgesics with similar potency is that that there does not appear to be a risk of dependence or tolerance with ketorolac use.
Vanderbilt Eye Institute, Nashville, Tennessee, United States
Planned Parenthood League of Massachusetts, Boston, Massachusetts, United States
Stollery Children's Hospital, Edmonton, Alberta, Canada
Alberta Children's Hospital, Calgary, Alberta, Canada
Massachusetts General Hospital, Charlestown, Massachusetts, United States
Unicamp, Campinas, Sao Paulo, Brazil
Akron Children's Hospital, Akron, Ohio, United States
Stollery Children's Hospital, Edmonton, Alberta, Canada
IOT - Instituto de Ortopedia e Traumatologia, Sao Paulo, SP, Brazil
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.